China NMPA Product Recall - Electric Hospital Beds

On June 30, 2021, the National Medical Products Administration (NMPA) announced a voluntary Class III recall initiated by Stryker Medical, specifically through its subsidiary Stryker (Beijing) Medical Devices Co., Ltd. The recall primarily involves Electrical Hospital Beds and other associated medical devices. The core issue prompting this action is a discrepancy in the intended use versus the actual distribution scope of these products in China. These devices are designed and approved for use within clinical institutional settings, not for personal use in home environments. Consequently, the sale of these particular products to individual users within China falls outside their authorized scope, necessitating corrective action. Stryker Medical has taken the initiative to recall these items to ensure compliance with regulatory frameworks and to address the appropriate usage context for their specialized medical equipment. Detailed information regarding specific models, specifications, and batch numbers is available in the "Medical Device Recall Event Report Form" provided by the manufacturer. This recall underscores the importance of adhering to regulatory guidelines concerning product distribution and appropriate user environments for medical devices.